The conference in 2009 will be the first opportunity to present and discuss results from the initial TSC clinical trials and additional data from basic research and to discuss plans for new clinical trials utilizing mTOR inhibitors and other drug targets. There are significant research opportunities to be discussed and addressed, and the planned conference will lead to new collaborations and new research avenues for TSC.
Additional Information: Conference Web Site